Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003

Benzer Materyaller

• Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
  Yazar:: Hann, I, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
  Yazar:: Chessels, J, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)